BEVERLY UZOMA: Open Payments
NPI 1467124933 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,569 in 69 payments from 18 companies in 2025. Trend: 2023 $1,610 · 2024 $1,396 · 2025 $1,569
Food & beverage: $1,569
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $293 |
| Novo Nordisk Inc | 9 | $190 |
| AstraZeneca Pharmaceuticals LP | 8 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
| Axsome Therapeutics, Inc. | 4 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| Exact Sciences Corporation | 3 | $86 |
| Lilly USA, LLC | 4 | $79 |
| ABBVIE INC. | 4 | $62 |
Products named: NURTEC ODT, JARDIANCE, Kerendia, BREZTRI, Auvelity, Ozempic, CAPLYTA, MOUNJARO.
Industry payments across MD — which companies pay providers there.
